What AI says about Clinical Accelerator

Data as of Oct 20, 2026Based on 1,300 AI responsesReviewed by Dimitry Apollonsky

Mentioned in

<1%

across Clinical Accelerator’s markets · since Jul 5

The market map

Mentioned in

=1FaacMentioned in 44%Avg. position 14.9
=1HySecurityMentioned in 42%Avg. position 49.4
=3Biomedical Advanced Research and Development Authority (BARDA)Mentioned in 31%Avg. position 28.9
=3Congressionally Directed Medical Research Programs (CDMRP)Mentioned in 26%Avg. position 5.3
=6Cystic Fibrosis FoundationMentioned in 21%Avg. position 6.4
=6NIH Grants & FundingMentioned in 20%Avg. position 2.9
=6Byan SystemsMentioned in 20%Avg. position 4.1
=6LiftMasterMentioned in 18%Avg. position 7.1
=11Medical CountermeasuresMentioned in 12%Avg. position 4.5
=11Leukemia & Lymphoma SocietyMentioned in 11%Avg. position 8.1
=11The Michael J. Fox Foundation for Parkinson's ResearchMentioned in 10%Avg. position 7.9
=11National Cancer InstituteMentioned in 9%Avg. position 5.4
=11TYMETALMentioned in 7%Avg. position 6.1
=11California Institute for Regenerative MedicineMentioned in 7%Avg. position 7.2